Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy

Cisplatin (cDDP) remains one of the first-line chemotherapeutic agents for gastric cancer (GC) treatment, and resistance to cDDP is the major limitation in its clinical application. Mechanisms of cDDP resistance have been shown to be varied and complicated. Aquaporin 3 (AQP3) has been demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xuqiang, Wang, Yao, Zhou, Yangchun, Wen, Jianfei, Wang, Shoulin, Shen, Lizong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107998/
https://www.ncbi.nlm.nih.gov/pubmed/27867537
http://dx.doi.org/10.1038/cddiscovery.2016.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107998/
https://www.ncbi.nlm.nih.gov/pubmed/27867537
http://dx.doi.org/10.1038/cddiscovery.2016.87

Ejemplares similares